Clinical trial
Gemcitabine in Pretreated/Refractory NK/T Cell Lymphoma
NCT01660568 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gemcitabine in Pretreated/Refractory NK/T Cell Lymphoma
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- January 31, 2013
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nk/t cell lymphoma